💊 The Cure Costs More Than the Disease

Big Pharma's Price-Fixing Scandal Proves What We All Knew: It's Never Been About Health

By The Mayor of Funkytown — Political Writer, Resistance Organizer, and Reluctant Expert on Corporate Greed in a Lab Coat

Insulin didn’t suddenly become more complicated to produce. Antibiotics aren’t more expensive because the science changed.
They cost more because a handful of pharmaceutical executives decided they should.

This week, a sweeping international investigation revealed that some of the world’s largest pharmaceutical companies colluded to drive up prices of essential medications, including insulin, antibiotics, and cancer drugs. Internal emails and whistleblower documents confirmed what many of us have long suspected: prices weren’t responding to the market — they were creating the market.

“If we all just hold the line on price, no one will undercut us.”
— Internal email, European Commission investigative file, July 2025

This isn’t about capitalism.
This is cartel logic, with a stethoscope.

---

🚨 The Conspiracy to Kill Affordability

The investigation—led jointly by the European Commission, U.S. Federal Trade Commission, and India’s Competition Commission—exposed how executives coordinated prices across borders, often through third-party "consultants" and encrypted group chats designed to avoid direct culpability.

Here’s what’s been confirmed:

• Insulin prices tripled across North America and Europe over six years — despite no change in the formula or production method.

• Generic antibiotics were deliberately rationed, with internal memos suggesting “strategic scarcity” as a pricing tactic.

• Cancer drug price spikes were referred to in internal memos as “opportunity windfalls.”

These weren’t market fluctuations. These were corporate choices designed to maximize profit by minimizing access to life-saving treatment.

And in the process, they turned medical necessity into economic warfare.

---

💵 Innovation, or Extraction?

Pharma giants often argue that high prices are necessary to fund research and innovation. But let’s be honest — if we follow the money, it doesn’t lead to the lab. It leads to the boardroom.

While drug prices soared:

• R&D spending remained flat or declined for several companies now under investigation.

• Executive compensation exploded, with multiple CEOs earning north of $40 million per year in salary, bonuses, and stock.

• Share buybacks took precedence over investment in future cures.

These companies weren’t struggling to innovate — they were succeeding at extraction. Extracting money from the sick, the desperate, and the barely insured. Extracting value from government subsidies while lobbying to crush competitors and extend monopolies.

And yes — in many cases, the very drugs they marked up were originally developed with public funding.

---

🧠 This Affects You — Even If You Think It Doesn’t

You might be healthy. You might have insurance. You might think this isn’t your fight.

But here’s why it is:

• If you ever need insulin, you’ll pay for their price games.

• If your child gets sick and the medication is suddenly $400, you’ll pay.

• If your local hospital can’t stock antibiotics because a multinational cartel rigged the market, you will absolutely pay.

And even if you don’t, your taxes already are.
These same companies are pocketing government contracts, subsidies, and tax breaks, while making you overpay at the pharmacy.

This isn’t just about your wallet. It’s about what happens when health becomes a hostage situation.

---

⚖️ What Comes Next?

Expect these headlines in the coming days:

• “Pharma companies deny wrongdoing.”

• “Temporary price freeze announced while investigations proceed.”

• “Executive steps down with $22 million severance package.”

Here’s what we won’t see unless the pressure stays high:

• Criminal charges for executives who knowingly manipulated life-saving drug access.

• Price restitution for the families who paid thousands for medicine that should’ve cost pennies.

• Reform that sticks, not just a PR cleanup campaign and a few reshuffled org charts.

The question is no longer whether Big Pharma can be trusted.
The question is whether we’ll let them walk away with a slap on the wrist — again.

---

🧬 Final Dose

They said the high price of medicine paid for the future.
But all it paid for was yachts, lobbyists, and quarterly earnings calls.

This was never about curing the sick. It was about monetizing suffering.

And the worst part? They think we’ll forget.
Let’s not.

---

✊ If this made you furious, you're not alone.

Help us hit 2,000 subscribers by September 1 so we can keep publishing what others won’t.
Every share, like, and subscribe keeps this work alive — and keeps the pressure on.

Subscribe, share, and never shut up.

#BigPharma #InsulinScandal #HealthcareJustice #GreedKills #PharmaCartel #SubstackVoices #ResistanceWriting